Σύγκριση μεθόδων
Εξετάστε τις επιλεγμένες μεθόδους δίπλα-δίπλα· οι γραμμές που διαφέρουν επισημαίνονται.
| FACT-Prostate: Λειτουργική Αξιολόγηση Θεραπείας Καρκίνου× | UCLA Prostate Cancer Index× | |
|---|---|---|
| Πεδίο | Ογκολογία | Ογκολογία |
| Οικογένεια | Process / pipeline | Process / pipeline |
| Έτος προέλευσης≠ | 1997 | 1998 |
| Δημιουργός≠ | Esper, P., et al. (built on Cella, D. F. FACT-G framework) | Litwin, M. S., et al. |
| Τύπος | Self-report questionnaire | Self-report questionnaire |
| Θεμελιώδης πηγή≠ | Esper, P., Mo, F., Chodak, G., Sinner, M., Cella, D., & Pienta, K. J. (1997). Measuring quality of life in men with prostate cancer using the Functional Assessment of Cancer Therapy-Prostate instrument. Urology, 50(6), 920–928. DOI ↗ | Litwin, M. S., Hays, R. D., Fink, A., Ganz, P. A., Leake, B., & Brook, R. H. (1998). The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care, 36(7), 1002–1012. DOI ↗ |
| Εναλλακτικές ονομασίες≠ | FACT-P | UCLA PCI, PCI |
| Συναφείς | 5 | 5 |
| Σύνοψη≠ | The FACT-Prostate (FACT-P) is a disease-specific quality-of-life instrument for men with prostate cancer, combining the 27-item FACT-G core with a 12-item prostate-specific subscale addressing urinary, sexual, and bowel function concerns. Developed and validated by Esper et al. in 1997, it is a standard outcome measure in prostate cancer clinical trials and clinical practice. | The UCLA Prostate Cancer Index (UCLA PCI) is a 20-item, prostate-cancer-specific quality-of-life instrument focused on functional outcomes (urinary, sexual, bowel) rather than general cancer QoL. Developed by Litwin et al. in 1998, it has become the standard functional assessment tool in prostate cancer outcomes research, particularly for treatment comparison studies evaluating surgical vs. radiation outcomes. |
| ScholarGateΣύνολο δεδομένων ↗ |
|
|